Cost-effectiveness of the Aerobika* oscillating positive expiratory pressure device in the management of COPD exacerbations

INTRODUCTION: COPD places a huge clinical and economic burden on the US health care system, with acute exacerbations representing a key driver of direct medical costs. Current treatments, although effective in reducing symptoms and limiting exacerbations, do not adequately target the underlying dise...

Descripción completa

Detalles Bibliográficos
Autores principales: Khoudigian-Sinani, Shoghag, Kowal, Stacey, Suggett, Jason A, Coppolo, Dominic P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655131/
https://www.ncbi.nlm.nih.gov/pubmed/29089755
http://dx.doi.org/10.2147/COPD.S143334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655131/
https://www.ncbi.nlm.nih.gov/pubmed/29089755
http://dx.doi.org/10.2147/COPD.S143334

Ejemplares similares